| abstract |
Using cells derived from umbilical cord tissue to stimulate and support angiogenesis in peripheral vascular disease patients, improve blood flow, regenerate, repair and ameliorate skeletal muscle injured by peripheral ischemic events, and protect skeletal muscle from ischemic injury Compositions and methods are disclosed. In particular, a method of treating a umbilicus-derived cell and a patient with peripheral vascular disease using fibrin glue is disclosed. |